Quince Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-116/11/26 | New | $0 | $0 | Equity Only | 06b | SEC linkSEC |
| 2026-06-116/11/26 | New | $114,720,542 | $114,720,542 | Equity Only | 06b | SEC linkSEC |
| 2025-07-017/1/25 | New | $11,488,304 | $11,488,304 | Equity Only | 06b | SEC linkSEC |
| 2018-05-315/31/18 | New | $84,466,700 | $84,466,700 | Equity Only | 06b | SEC linkSEC |
| 2017-02-142/14/17 | New | $7,600,000 | $7,600,000 | Debt Only | 06b | SEC linkSEC |
| 2016-01-051/5/16 | New | $7,918,642 | $7,918,642 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Luca Benatti | Director |
| June Bray | Director |
| Stephen Dominy | Director |
| Kristen Gafric | Executive |
| Brendan Hannah | Executive |
| David Lamond | Director |
| Casey Lynch | Director, Executive |
| Margi Mc Loughlin | Director |
| Rajiv Patni | Director |
| Roger Quy | Director |
| Brigette Roberts | Director, Executive |
| Una Ryan | Director |
| Charles Ryan | Executive |
| Christopher Senner | Director |
| Dirk Thye | Director, Executive |
| Ilan Zipkin | Director |
Industry: Biotechnology (See others in industry)
Address:
611 Gateway Blvd., Suite 273
South San Francisco, CA, 94080
Phone: 415-910-5717
South San Francisco, CA, 94080
Phone: 415-910-5717